Doctor profile · Federal record
Dr. Charles Franklin, M.D.
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Lynchburg, VA
- NPI 1477559243
- Accepts Medicare
- MIPS 71.8 / 100 · 2023
- 45 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
2405 Atherholt Road
Lynchburg, VA 24501
(434) 485-8517 - Additional location
-
2360 Maryland RD
Willow Grove, PA 19090
(215) 657-6776
fax (267) 913-5961 - Additional location
-
292 Saint Charles Way
York, PA 174024648
(717) 356-4250
fax (717) 812-6024 - Mailing address
-
2360 Maryland RD
Willow Grove, PA 190901709
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- August 21, 2025
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Virginia #0101279754 · Pennsylvania #MD027056E
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477559243. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
40,419
Distinct HCPCS
10
Medicare allowed
$543,890
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 13,960 | 13 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,200 | 16 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 4,980 | 83 | $23 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 3,990 | 11 | $10 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 3,700 | 14 | $14 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,810 | 19 | $34 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,700 | 16 | $41 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 297 | 211 | $135 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 253 | 41 | $1 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 166 | 108 | $79 |
In context: peer comparison
Among 1 peers in Lynchburg Rheumatology Physician, average services per provider: 2,377. This provider delivers 17× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
1,068
Patients
291
Total drug cost
$421,679
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 160 | 48 | $1,436 |
| Gabapentin | Generic | 127 | 31 | $2,074 |
| Methotrexate (Methotrexate Sodium) | Brand | 117 | 38 | $3,839 |
| Hydroxychloroquine Sulfate | Generic | 89 | 25 | $3,954 |
| Celecoxib | Generic | 86 | 21 | $2,917 |
| Duloxetine Hcl | Generic | 82 | 22 | $2,151 |
| Meloxicam | Generic | 74 | 26 | $420 |
| Leflunomide | Generic | 59 | 17 | $3,989 |
| Enbrel Sureclick (Etanercept) | Brand | 53 | 0 | $396,175 |
| Cyclobenzaprine Hcl | Generic | 50 | 14 | $470 |
Frequently asked questions
What is Dr. Charles Franklin's medical specialty?
Dr. Charles Franklin practices Rheumatology Physician in Lynchburg, VA.
Where does Dr. Charles Franklin practice?
Dr. Charles Franklin practices at 2405 Atherholt Road, Lynchburg, VA 24501. Office phone: 4344858517.
What is Dr. Charles Franklin's NPI?
Dr. Charles Franklin's National Provider Identifier (NPI) is 1477559243, issued by NPPES.
Does Dr. Charles Franklin accept Medicare assignment?
Yes. Dr. Charles Franklin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Franklin commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.